CAPUTO, MARIANGELA
 Distribuzione geografica
Continente #
EU - Europa 154
AS - Asia 88
NA - Nord America 53
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
AF - Africa 1
Totale 310
Nazione #
RU - Federazione Russa 125
US - Stati Uniti d'America 52
SG - Singapore 29
CN - Cina 21
VN - Vietnam 16
IT - Italia 13
BR - Brasile 6
IN - India 5
DE - Germania 4
JP - Giappone 4
KR - Corea 4
HK - Hong Kong 3
GB - Regno Unito 2
IE - Irlanda 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CA - Canada 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
IL - Israele 1
IQ - Iraq 1
LV - Lettonia 1
NL - Olanda 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 302
Città #
Moscow 49
San Jose 22
Singapore 19
Ho Chi Minh City 7
Hefei 6
Ashburn 5
Beijing 5
Council Bluffs 4
Munich 4
Santa Clara 4
Seoul 4
Bengaluru 3
Da Nang 3
Hong Kong 3
São Paulo 3
Aversa 2
Biên Hòa 2
Dublin 2
Hillsboro 2
Naples 2
Osaka 2
Viterbo 2
Warsaw 2
Amsterdam 1
Belém 1
Brooklyn 1
Buffalo 1
Bến Tre 1
Chennai 1
Formia 1
Guangzhou 1
Haiphong 1
Hanoi 1
Istanbul 1
Jerusalem 1
Johannesburg 1
Kyiv 1
Lappeenranta 1
London 1
Manchester 1
Marlborough 1
Montreal 1
New York 1
Newark 1
Nola 1
Osasco 1
Pescara 1
Phoenix 1
Poços de Caldas 1
Prague 1
Quận Một 1
Riga 1
Salt Lake City 1
Stockholm 1
Xizhi District 1
Totale 189
Nome #
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 135
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial 124
The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study 18
Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts 18
BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor 15
Totale 310
Categoria #
all - tutte 1.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 1 0 0 1 2
2024/202527 1 0 3 3 7 4 2 2 1 1 1 2
2025/2026269 16 18 11 10 18 114 8 33 10 25 4 2
2026/202710 0 10 0 0 0 0 0 0 0 0 0 0
Totale 310